Table 2.
Cox regression analysis of biochemical disease free survival (BDFS) and overall survival (OS) before and after propensity score matching (PSM)
| Biochemical disease free survival | Overall survival | |||||||||||
| Before PSM | After PSM | Before PSM | After PSM | |||||||||
| HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
| Age >75 | 0.29 | 0.03–2.37 | 0.253 | 4.08 | 0–1 | 1.000 | 1.54 | 0.62–3.85 | 0.348 | 1.46 | 0.42–5.05 | 0.549 |
| PS | 1.26 | 0.49–3.20 | 0.624 | 1.09 | 0.26–4.44 | 0.903 | 1.93 | 1.08– 3.42 | 0.025 | 0.35 | 0.05–2.55 | 0.306 |
| Previous abdominal surgery | 1.68 | 0.45–6.28 | 0.436 | 1.58 | 0.35–7.09 | 0.545 | 1.27 | 0.50–3.24 | 0.612 | 1.25 | 0.36–4.29 | 0.719 |
| Hypertension | 1.45 | 0.36–5.83 | 0.593 | 1.08 | 0.24–4.87 | 0.911 | 1.20 | 0.48–3.00 | 0.687 | 0.77 | 0.23–2.53 | 0.670 |
| Diabetes mellitus | 4.94 | 0–1 | 1 | 5.00 | 0–1 | 1.000 | 2.84 | 1.02– 7.93 | 0.045 | 0.77 | 0.09–6.07 | 0.809 |
| Initial PSA | 1.10 | 0.96–1.27 | 0.155 | 1.13 | 0.97–1.33 | 0.111 | 1.04 | 0.93–1.16 | 0.414 | 1.05 | 0.91–1.21 | 0.481 |
| Gleason Score | 1.32 | 0.35–4.95 | 0.678 | 1.96 | 0.43–8.77 | 0.379 | 1.58 | 0.64–3.91 | 0.315 | 0.72 | 0.21–2.47 | 0.606 |
| NCCN class | 1.33 | 0.35–4.96 | 0.671 | 2.22 | 0.43–11.49 | 0.338 | 1.63 | 0.64–4.16 | 0.300 | 0.94 | 0.28–3.09 | 0.925 |
| ADT | 1.01 | 0.21–4.90 | 0.982 | 1.20 | 0.23–6.18 | 0.828 | 1.48 | 0.53–4.12 | 0.448 | 2.04 | 0.59–6.99 | 0.254 |
| RT treatment | 1.11 | 0.29–4.22 | 0.868 | 0.92 | 0.20–4.14 | 0.920 | 0.60 | 0.22–1.61 | 0.312 | 1.28 | 0.36–4.53 | 0.698 |